Solventum

Solventum (Nasdaq/NYSE: SOLV) is a Health Care Technology company operating within the Health Care sector of the US equity market.

Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.

The company reports trailing twelve-month revenue of $2.01B and net income of $13.00M.

Key metrics include a return on equity of 0.3%, a debt-to-equity ratio of 1.84.

Use FINOTAUR to track SOLV's price action, review fundamentals, and stay current with company news — all in one research dashboard.